1) Nonalcoholic fatty liver disease
非酒精性脂肪性肝病
1.
Analysis of Perilipin and ADRP changes in the nonalcoholic fatty liver disease;
非酒精性脂肪性肝病发生中Perilipin和ADRP表达变化实验研究
2.
Secretory status of pancreas and pathogenesis of insulin resistance in rat with nonalcoholic fatty liver disease;
非酒精性脂肪性肝病大鼠胰腺分泌状态及胰岛素抵抗观察
3.
Nonalcoholic Fatty Liver Disease with Increased Incidence of Metabolic Disorders;
非酒精性脂肪性肝病患者代谢紊乱发病率增高
2) Non-alcoholic fatty liver disease
非酒精性脂肪性肝病
1.
Significance and effect of liver X receptor α and sterol regulatory element binding protein-1c in non-alcoholic fatty liver disease in rats;
非酒精性脂肪性肝病大鼠肝X受体α和固醇调节元件结合蛋白-1c的表达及意义
2.
Treating non-alcoholic fatty liver disease accompanied by hyperlipidemia with Xuezhikang Capsule;
血脂康胶囊治疗合并高脂血症的非酒精性脂肪性肝病
3.
The Analysis of The efficacy and risk factors in obesity with non-alcoholic fatty liver disease subjects treated with orlistat.;
奥利司他对肥胖伴非酒精性脂肪性肝病的作用及危险因素的影响
3) NAFLD
非酒精性脂肪性肝病
1.
Influences of Aerobic Exercises on Body Mass and Liver Ultrasound Exam of NAFLD Patients;
有氧运动对非酒精性脂肪性肝病身体成分和肝脏声像图的影响
2.
Study on the Copy of NAFLD Models Through Corn Oil;
玉米油复制非酒精性脂肪性肝病动物模型的研究
3.
Application of hepatoprotectors in prevention and treatment of NAFLD.
保肝药物防治非酒精性脂肪性肝病临床价值
4) Nonalcoholic fatty liver diseases
非酒精性脂肪性肝病
1.
Therapeutic effect of weight loss combining bicyclol on primary nonalcoholic fatty liver diseases;
减轻体重联合百塞诺治疗非酒精性脂肪性肝病疗效分析
2.
Objetive:To investigate the efficacy and safety of Jianpi Bushen herb in the treatment of nonalcoholic fatty liver diseases(NAFLD).
目的:研究健脾补肾中药治疗非酒精性脂肪性肝病的疗效和安全性。
5) nonalcoholic fatty liver disease(NAFLD)
非酒精性脂肪性肝病(NAFLD)
补充资料：酒精性肝病
酒精性肝病
alcoholic liver disease
由酒精中毒引起肝脏疾病，主要有酒精性脂肪肝、酒精性肝炎及肝硬化。酒精性脂肪肝是因乙醇在肝内代谢为乙醛及乙酸时，辅酶Ⅰ转变为还原辅酶Ⅰ增加，抑制三羧酸循环，肝内脂肪酸合成增多而致脂肪肝。酒精性肝炎为肝细胞肿胀，线粒体变形，胞质中出现乙醇透明小体，肝细胞变性，周围纤维化。严重者可出现小结节性肝硬化。临床常表现为肝肿大，常与病变程度相关，轻者无症状，重者可有肝炎表现。肝硬化者除有一般肝硬化表现外，还有慢性酒精中毒引起的掌挛缩和脑病等表现。无特异性治疗，以高热量平衡饮食、护肝、补充维生素等；肝硬化则同其他肝硬化一样处理。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条